BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36077769)

  • 1. Novel Insights into miR-944 in Cancer.
    Shen J; Wang Q; Liang C; Su X; Ke Y; Mao Y; Fang J; Duan S
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis.
    Shen J; Liang C; Su X; Wang Q; Ke Y; Fang J; Zhang D; Duan S
    Biomark Res; 2022 Sep; 10(1):72. PubMed ID: 36175921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Expression of miR-1301 in Human Cancer.
    Zhong C; Dong Y; Zhang Q; Yuan C; Duan S
    Front Oncol; 2021; 11():789626. PubMed ID: 35070996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-1908 Dysregulation in Human Cancers.
    Shen J; Wu Y; Ruan W; Zhu F; Duan S
    Front Oncol; 2022; 12():857743. PubMed ID: 35463352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of miR-411 in cancer: Causative factor for pathogenesis, diagnosis and prognosis.
    Zou M; Shen J; Wu Y; Zhong C; Fang L; Zhu F; Duan S
    Biomed Pharmacother; 2022 May; 149():112896. PubMed ID: 35358797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells.
    Zhang J; Xu C; Gao Y; Wang Y; Ding Z; Zhang Y; Shen W; Zheng Y; Wan Y
    Front Oncol; 2020; 10():215. PubMed ID: 32158694
    [No Abstract]   [Full Text] [Related]  

  • 7. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 8. Crucial Roles of miR-625 in Human Cancer.
    Zhang M; Xiong F; Zhang S; Guo W; He Y
    Front Med (Lausanne); 2022; 9():845094. PubMed ID: 35308517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of microRNA-4443 (miR-4443) in human diseases.
    Mao Y; Shen J; Wu Y; Wenjing R; Zhu F; Duan S
    Bioengineered; 2022 Jun; 13(6):14770-14779. PubMed ID: 36250718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-940 is a new biomarker with tumor diagnostic and prognostic value.
    Li H; Li Y; Tian D; Zhang J; Duan S
    Mol Ther Nucleic Acids; 2021 Sep; 25():53-66. PubMed ID: 34168918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-874: An Important Regulator in Human Diseases.
    Zhang Q; Zhong C; Yan Q; Zeng LH; Gao W; Duan S
    Front Cell Dev Biol; 2022; 10():784968. PubMed ID: 35465322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.
    Chen H; Cheng S; Xiong W; Tan X
    Ann Transl Med; 2021 Jul; 9(14):1156. PubMed ID: 34430597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells
    Zhang S; Wang Q; Li W; Chen J
    Front Mol Biosci; 2021; 8():793493. PubMed ID: 35127818
    [No Abstract]   [Full Text] [Related]  

  • 17. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH; He SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and integrated analysis of differentially expressed lncRNAs and circRNAs reveal the potential ceRNA networks during PDLSC osteogenic differentiation.
    Gu X; Li M; Jin Y; Liu D; Wei F
    BMC Genet; 2017 Dec; 18(1):100. PubMed ID: 29197342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub lncRNA ceRNAs in multiple sclerosis based on ceRNA mechanisms.
    Ding Y; Li T; Yan X; Cui M; Wang C; Wang S; Zhang F; Zhang R
    Mol Genet Genomics; 2021 Mar; 296(2):423-435. PubMed ID: 33507382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.